drugset / Trial / NCT01667289

Radiotherapy Alone Versus Concurrent Chemoradiation in Low Risk NK/T-cell Lymphoma

NCT01667289 ↗

Phase 2 Terminated 4 enrolled Fudan University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to prove the superiority of concurrent chemoradiation compared with radiotherapy alone in patients with low risk NK/T-cell lymphoma.

Timeline

Start
2012-06
Primary completion
2015-06
Completion
2017-06

Outcome

Outcome not reported

Stopped: “unexpected high grade of mucositis observed”

Drugs

EvaluationDrugModalityDoseRoute
Subject Methotrexate Small molecule 40 mg/m2 —